Cases 31 - 40 of 57
Teva Pharmaceuticals International GmbH et al v. Mylan Laboratories Limited
as 1:2017cv01790
Plaintiff:
Teva Pharmaceuticals International GmbH , Cephalon, Inc. and Eagle Pharmaceuticals, Inc.
Defendant:
Mylan Laboratories Limited
Cause Of Action: 28 U.S.C. § 2201
HORIZON PHARMA, INC., ET AL. V. DR. REDDY'S LABORATORIES, INC., ET AL.
as 2:2017cv11635
Petitioner:
BAKER BOTTS LLP and PHV STEPHEN M. HASH
Defendant:
LUPIN LTD, MYLAN PHARMACEUTICALS INC., MYLAN LABORATORIES LIMITED and others
Plaintiff:
HORIZON PHARMA, INC and POZEN INC.
Cause Of Action: Motion to Quash
Horizon Pharma, Inc. et al v. Dr. Reddy's Laboratories Inc. et al
as 1:2017mc00997
Movant:
Baker Botts LLP and Stephen M. Hash
Defendant:
Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd., Lupin Ltd. and others
Respondent:
Dr. Reddy's Laboratories Inc. and Dr. Reddy's Laboratories Ltd.
Plaintiff:
Horizon Pharma, Inc. and Pozen Inc.
Cause Of Action: Motion to Quash
Horizon Pharma, Inc. et al v. Dr. Reddy's Laboratories Inc. et al
as 1:2017cv00997
Defendant:
Dr. Reddy's Laboratories Ltd., Mylan Pharmaceuticals Inc., Lupin Ltd. and others
Petitioner:
Stephen M. Hash and Baker Botts LLP
Plaintiff:
Horizon Pharma, Inc. and Pozen Inc.
Genzyme Corporation et al v. Mylan Laboratories Limited et al
as 1:2016cv00188
Plaintiff:
Genzyme Corporation , Southern Research Institute and Sanofi-Aventis U.S. LLC
Defendant:
Mylan Laboratories Limited, Mylan Pharmaceuticals Inc. and Mylan Inc.
Cause Of Action: 28 U.S.C. § 1338
GENZYME CORPORATION et al v. MYLAN LABORATORIES LIMITED et al
as 2:2016cv05828
Plaintiff:
GENZYME CORPORATION , SOUTHERN RESEARCH INSTITUTE and SANOFI-AVENTIS U.S. LLC.
Defendant:
MYLAN LABORATORIES LIMITED, MYLAN PHARMACEUTICALS INC. and MYLAN INC.
Cause Of Action: 35 U.S.C. § 271
HORIZON PHARMA, INC. et al v. MYLAN PHARMACEUTICALS INC. et al
as 3:2016cv04921
Plaintiff:
HORIZON PHARMA, INC. , HORIZON PHARMA USA, INC. and POZEN INC.
Defendant:
MYLAN PHARMACEUTICALS INC., MYLAN LABORATORIES LIMITED and MYLAN, INC.
Cause Of Action: 35 U.S.C. § 271
Javelin Pharmaceuticals, Inc. et al v. Mylan Laboratories Limited et al
as 1:2016cv00059
Plaintiff:
Javelin Pharmaceuticals, Inc. , Hospira, Inc. and Janssen Pharmaceutica N.V.
Defendant:
Mylan Laboratories Limited, Mylan Inc. and Mylan Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271
Javelin Pharmaceuticals, Inc. et al v. Mylan Laboratories Limited et al
as 1:2016cv00224
Plaintiff:
Javelin Pharmaceuticals, Inc. , Hospira, Inc. and Janssen Pharmaceutica N.V.
Defendant:
Mylan Laboratories Limited, Mylan Inc. and Mylan Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271
BOEHRINGER INGELHEIM PHARMACEUTICALS INC. et al v. SUN PHARMACEUTICAL INDUSTRIES LTD et al
as 3:2016cv01727
Plaintiff:
BOEHRINGER INGELHEIM PHARMACEUTICALS INC. , BOEHRINGER INGELHEIM INTERNATIONAL GMBH , BOEHRINGER INGELHEIM CORPORATION and others
Defendant:
SUN PHARMACEUTICAL INDUSTRIES LTD, SUN PHARMA GLOBAL FZE, MYLAN INC. and others
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
